Medacta Group SA

Swiss Stock Exchange MOVE.SW

Medacta Group SA Gross Profit for the year ending December 31, 2023: USD 383.94 M

Medacta Group SA Gross Profit is USD 383.94 M for the year ending December 31, 2023, a 17.55% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

Medacta Group SA Gross Profit for the year ending December 31, 2022 was USD 326.61 M, a 9.82% change year over year.
Medacta Group SA Gross Profit for the year ending December 31, 2021 was USD 297.39 M, a 13.63% change year over year.
Medacta Group SA Gross Profit for the year ending December 31, 2020 was USD 261.73 M, a 4.26% change year over year.
Medacta Group SA Gross Profit for the year ending December 31, 2019 was USD 251.04 M, a 7.53% change year over year.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

Swiss Stock Exchange: MOVE.SW

Medacta Group SA

CEO	Dr. Francesco Siccardi
IPO Date	April 3, 2019
Location	Switzerland
Headquarters	Strada Regina, 34
Employees	1,826
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Key trends

Past 5 years